The Company develops, manufactures and markets medical devices to treat the soft palate component of sleep disordered breathing, which includes OSA and snoring.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
Unclear benefit in OSA combined with questionable reimbursement climate unlikely to drive near-term growth.